View Older Stories View More Recent Stories

Mar 6, 2025 07:59AM Bernstein Reiterates Market Perform on Novo Nordisk (NOVOB:DC) (NVO) Following NovoCare Pharmacy Launch
Mar 5, 2025 09:26AM Amgen (AMGN) Starts Late-stage Studies Of Monthly Obesity Drug - Bloomberg, Citing Comments at Conf.
Mar 5, 2025 07:44AM Bernstein on Eli Lilly (LLY): '2025 is a Catalyst-Rich Year for LLY'
Mar 4, 2025 06:49AM Bernstein: 'Eli Lilly (LLY) Continues to Outgrow Novo'
Feb 28, 2025 08:15AM Lilly's (LLY) Jaypirca recommended by CHMP for approval in EU for adults with r/r CLL
Feb 28, 2025 07:48AM Bernstein on Eli Lilly (LLY) Amid US Biopharma Policy: 'LLY Leans In'
Feb 26, 2025 02:01PM Eli Lilly to invest another $27 billion in U.S. manufacturing
Feb 26, 2025 12:19PM Deutsche Bank Reiterates Buy Rating on Eli Lilly (LLY) Amid New U.S. Investment
Feb 26, 2025 10:00AM JPMorgan Reiterates Overweight Rating on Eli Lilly (LLY)
Feb 26, 2025 09:30AM Eli Lilly & Co. (LLY) to more than double U.S. manufacturing investment since 2020 exceeding $50B
Feb 26, 2025 09:23AM BMO Capital Reiterates Outperform on Eli Lilly (LLY) After Self Pay Program Expansion
Feb 26, 2025 06:39AM Eli Lilly (LLY) Lowers Zepbound Price; Bernstein: 'This is Something We'd Been Hoping to See'
Feb 25, 2025 08:06AM Organovo's (ONVO) FXR Program, including FXR314, Acquired by Eli Lilly (LLY)
Feb 25, 2025 06:46AM Eli Lilly & Co. (LLY) launches additional Zepbound vial doses and offers new savings for self-pay patients
Feb 24, 2025 07:19AM Bernstein Sees 'Clear Upside' for Eli Lilly's (LLY) Zepbound and Mounjaro Post FDA Announcement
Feb 22, 2025 04:00AM What's the current state of China's GLP-1 market?
Feb 21, 2025 11:31AM Eli Lilly & Co. (LLY) call put ratio 3.9 calls to 1 put as share price up 2.2%
Feb 20, 2025 05:30AM Eli Lilly & Co. (LLY) call put ratio 1.8 calls to 1 put amid price movement
Feb 19, 2025 04:19PM Eli Lilly & Co. (LLY) Files Mixed Shelf
Feb 10, 2025 05:37PM Eli Lilly announces $6.5 billion six-part note offering
Feb 7, 2025 06:45AM Eli Lilly & Co. (LLY) reports most patients on Omvoh for Crohn's disease achieved sustained clinical remission and endoscopic response at two years
Feb 6, 2025 06:47AM Eli Lilly & Co. (LLY) Tops Q4 EPS by 2c; offers outlook
Feb 6, 2025 05:59AM Bernstein on Eli Lilly (LLY) Following NOVO Read-Across: 'Good News for LLY'
Feb 6, 2025 05:49AM Eli Lilly & Co. (LLY) call put ratio 1.6 calls to 1 put into quarter results
Feb 6, 2025 02:00AM Eli Lilly Q4 earnings preview: Here’s what to expect
Feb 5, 2025 01:35PM Erste Group Upgrades Eli Lilly (LLY) to Buy
Feb 5, 2025 01:20PM Truist Securities Reiterates Buy Rating on Eli Lilly (LLY)
Feb 5, 2025 10:37AM Eli Lilly & Co. (LLY) call put ratio 1.4 calls to 1 put into quarter results
Feb 5, 2025 05:16AM Eli Lilly & Co. (LLY) call put ratio 1.7 calls to 1 put into quarter results
Feb 3, 2025 08:50AM Eli Lilly (LLY) PT Raised to $1,038 at Truist on 'Updated FY2024 and Announced FY2025 Guidance'
Jan 30, 2025 01:12PM Eli Lilly & Co. (LLY), Novo (NVO) see mid-day upside
Jan 28, 2025 02:55PM Tectonic shares tumble after rival drug trial termination
Jan 28, 2025 02:50PM Leerink Comments on Tectonic Therapeutics Inc. (TECX) Post Eli Lilly (LLY) Terminating volenrelaxin CKD
Jan 27, 2025 06:37AM Bernstein Reiterates Outperform Rating on Eli Lilly (LLY): 'Novo Punches Back, but LLY Still a Step Ahead'
Jan 24, 2025 12:14PM BofA Securities Reiterates Buy Rating on Eli Lilly (LLY)
Jan 23, 2025 10:00PM Eli Lilly & Co. (LLY) Morgan Stanley sees three potential scenarios in the compounders vs. FDA over Tirzepatide
Jan 23, 2025 05:53AM BofA Adjusts US 1 List
Jan 23, 2025 05:18AM Eli Lilly & Co. (LLY) call put ratio 2.1 calls to 1 put
Jan 21, 2025 04:51AM BofA Securities Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
Jan 17, 2025 09:44AM Leerink Partners Reiterates Outperform Rating on Eli Lilly (LLY)
Jan 17, 2025 07:11AM Eli Lilly (LLY) PT Lowered to $973 at Guggenheim
Jan 15, 2025 04:07PM Eli Lilly & Co. (LLY) Announces FDA Approval of Omvoh for Crohn's disease
Jan 15, 2025 10:24AM Bernstein SocGen Group Reiterates Outperform Rating on Eli Lilly (LLY) Despite 'Disappointing' GLP-1 Miss
Jan 15, 2025 05:24AM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)
Jan 15, 2025 04:59AM Wells Fargo Reiterates Overweight Rating on Eli Lilly (LLY)
Jan 15, 2025 04:58AM BofA Securities on Eli Lilly (LLY): 'a particularly good buying opportunity'
Jan 15, 2025 04:54AM Citi Reiterates Buy Rating on Eli Lilly (LLY)
Jan 15, 2025 04:51AM Eli Lilly & Co. (LLY) call put ratio 1.4 calls to 1 put as share price pulls back
Jan 14, 2025 09:01AM Lilly (LLY) provides update on 2024 revenue guidance, announces 2025 revenue guidance
Jan 13, 2025 01:20PM Eli Lilly & Co. (LLY) Asks Biden Administration to Pause Drug-price Negotiation - Bloomberg
View More Recent Stories View Older Stories